The First FDA-Approved Digital Pill — What It Means For Pharma Harsha Madannavar Justin Wang Helen Chen Read more
Related Practice Life Sciences & Pharma In mid-November 2017, the U.S. FDA approved Japan-based Otsuka Pharmaceutical’s Abilify MyCite— a first for digital medicine. 07312019140709
Published Articles Life Sciences & Pharma Shifting Geographic Priorities for Healthcare Companies Operating in Asia (Subscription… October 11, 2023
Executive Insights Life Sciences & Pharma Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives September 1, 2023
Executive Insights Life Sciences & Pharma EUnetHTA 21 — Transition to EU-wide HTAs: Implications for Pharma July 31, 2023
Executive Insights Life Sciences & Pharma Clinical Trial Challenges: Patient Recruitment and Diversity March 11, 2023